Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...

Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, ...

When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.

Former X CEO and senior NBCUniversal executive Linda Yaccarino has been named CEO of digital weight-loss firm eMed.

Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...